🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the platform has taken down violative material and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of members, filled with photos of weight loss, glowing testimonials and detailed instructions for preparing or injecting at home.

Within minutes of joining one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Inside these communities, messages show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram stated it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly serious medical dangers”.